NOT Adam Feuerstein (Parody) (@NotFeuerstein) header
NOT Adam Feuerstein (Parody) (@NotFeuerstein) profile picture

Parody acct. I am a dog whistle for short sellers and bear raids. The night-night king of bio. Selective quotes. Data is.

Joined February 2022
NOT Adam Feuerstein (Parody) retweeted
$SAVA Patent News - Aug 20th 2024
2
8
1
42
6,246
NOT Adam Feuerstein (Parody) retweeted
Official $SAVA R&R COVERAGE Oh and @ElemerPiros does have actually a PhD in neuroscience, not zoology or oceanography 🔥🩳🔥or bus/van driving expertise. Cheers Looking forward to RETHINK DATA
4
22
4
94
10,060
NOT Adam Feuerstein (Parody) retweeted
Replying to @BillAckman
Summary: What Business Insider did to @NeriOxman is happening every day to good researchers like Dr Haou Wang or @MIT in the case of Dr Ram Sasisekharan. 96.5% of misconduct allegation are false, but careers are ruined when they are smeared in the press. I am fighting for science with CureGuardian.org but need help. statnews.com/2023/06/14/ram-… nytimes.com/2023/10/28/healt… Details of the Daily Attack on Science: These fraud hungers post on pubpeer.com (@pubpeer) a cyberbully platform disguised as a science integrity platform. Mostly anonymous posters write flimsy accusations on topics they are not experts. They send complaints to the researchers' journals, institutions and funding sources. They then contact the press to get public articles written to pressure the various institutions to investigate their targets. As soon as the press writes about it, their careers are permanently damaged. Many go into serious depression, enter hospitals, or worse attempt suicide. 96.5% of research misconduct or fraud are FALSE, but they are all punished immediately. (Read here for the facts and siting of the 96.5% number xitter.gq/MattNachtrab/status/17…) The results are good researchers wasting time responding to anonymous fraud hunters' accusations. Their research is frequently permanently halted because the institution (i.e. @cuny in the case of Dr Haou Wang or @MIT in the case of Dr Ram Sasisekharan) Detailed post about the issue of false accusations in science and who is leading the attack on science: xitter.gq/MattNachtrab/sta… I am starting a non-profit called CureGuardian.org and funding it personally to help with legislation change, policy change, assist researchers accused so they can, and pursue defamation cases. I could use a ton of help because the people accused of research misconduct need to move mountains to respond to these allegations as you have seen with your wife. Message me to join the fight. I cannot do this alone, but mostly have been on my own to date. Li Many people are involved in this ongoing attack on science including @microbiomdigest, @cpiller and @ScienceMagazine , @adamfeuerstein at @statnews , and dozens of others that spam pubpeer and institutions. All accusations are not false, but when they are done publicly before a fair and thorough investigation, damage is done to many innocent victims. Detailed post about the issue of false accusations in science and who is leading the attack on science: xitter.gq/MattNachtrab/sta… $sava
Scientific research misconduct complainants (@schrag_matthew @MicrobiomDigest, @Thatsregrettab1, David Bredt, @geoffrey_pitt, and @adrian_h) and the journalists (@chris_said, @cpiller, @damiangarde, @Dereklowe, @adamfeuerstein, and @pubpeer) that write articles about research misconduct do not understand, do not respect, or ignore the laws that govern or the investigation procedures that journals, Institutions, and ORI are required to perform for as complaints are risen. They also do not comprehend fully, do not respect, or ignore the meaning (in investigation policy and law) of the inflammatory words used in their writings. All of these policies stress confidentiality of the complaint and the accused (look at the Pictures attached). The complainants and journalists willfully ignore and/or disrespect these confidentiality preferences to benefit from personal gains (advertising, reputation, compensation, competitive advantage, or other gains) from publicizing their accusations. Yesterday, @chris_said said Marc Tessier-Lavigne, Berislav Zlokovic, Hoau-Yan Wang, and Sylvain Lesné were “credibly accused of fraud”. This statement is FALSE and currently has 829,000 views and growing on X (Twitter). I think all of the researchers AND institutions defamed publicly should join forces and sue this group of complainants, co-conspirators, journalists, PubPeer and the companies that publish their accusations because they skip fair and thorough investigations to defame them. I am more than happy to help them organize this effort to protect science innovation in the pursuit of cures to disease. LET’S DO IT!!! Contact me and we can help stop this from spiraling worse and worse. I think ALL whistleblower (NIH, DOJ, SEC, and etc) awards should be ZERO if the parties making the complaint go public with their allegations prior to a completed investigation and the complainants evaluated for failing to adhere to the Good Faith provisions of those policies. WB policies need modification to accommodate this. (To be clear, this is not legal advice. I am not an attorney. An attorney would help determine if a defamation case is worth pursuing or justified against one or all of these people and organizations) This post goes in great detail into how the Research Misconduct complaint and investigation process actually works from raised concerns to federal charges to the researcher for crimes like fraud. Fraud is a legal term and a federal crime. The best way I can define it in this context is “willful intent to deceive for personal gain”. The simplest way to understand fraud is someone deceived you by taking money from you. Proving fraud requires actual evidence of willful intent and a clear financial gain that can be proven in court (an email that says “I faked the data in my Alzheimer’s paper so that I could get the licensing agreement from Pfizer and it worked!”). Using the word fraud crosses the line from Research Misconduct to a major crime with jail time as punishment. Using it on a post that gets 1m views would make me want to sue for defamation if I was one of those researchers. You will notice the professional journalists do not use terms like fraud often. It crosses a major line. Read below ALLLLLLL the way to the end as that is not determined till the end of likely a 3-5+ year thorough investigation with hearings and criminal charges, if a settlement is not obtained. My MAJOR complaint against these complainants and journalists is there is a very robust investigative process that ensures a fair and thorough investigation is completed. The journal or institution has confidentiality policies regarding the allegations and the name of the researcher until the proceedings are complete. When they leak or go public with the allegations these investigations are skipped and it destroys careers immediately and unjustifiably. The damage cannot be undone when an investigation eventually vindicates them. A VAST MAJORITY OF COMPLAINTS RESOLVE WITHOUT GUILT OF RESEARCH MISCONDUCT. The complainants, journalists, and @PubPeer need to read the overview below so they understand what they are skipping by publicly shaming researchers and institutions. Formal Research Misconduct Complaint and Investigation Process Nearly all of the complaints about research follow the laws written by ORI for research misconduct or COPE policies for scientific journals. There are institutional punishments (fired, demoted, and etc) from the school, retractions and corrections by journals, or federal jail and fines from ORI/HHS. Complaints of research misconduct come in a few ways to schools that receive HHS money to perform research: 1. Directly to the school/institution employing the researcher 2. Through a journal when they find potential research misconduct OR cannot determine if it occurred. Journals have an thorough evidence based investigation procedure they follow that is quite complex and typically follow guidelines laid out by @C0PE (Committee on Publication Ethic publicationethics.org/) 3. Through HHS, NIH, then to ORI (ori.hhs.gov/about-ori Office for Research Integrity, the independent government entity that oversees research integrity for the $40B+ per year that is spent by HHS) whistleblower complaints or other concerns raise HHS requires that institutions that receive money to have Research Misconduct procedures to manage the complaints received and investigate if necessary (@CUNY Policy 1.24 Research Misconduct is a great example policy.cuny.edu/wp-content/u…). They have to report to ORI annually a summary of Research Misconduct complaints and investigations and attest their procedures accurately reflect the Laws Regarding Research Misconduct (ecfr.gov/current/title-42/ch…) Researcher Disciplinary Process - The institution can use the results of their investigation to take disciplinary action in accordance with the policies at the school and union rules if applicable. The researcher can accept the punishment or request a hearing. ORI Misconduct Proceedings and Administrative Actions - This is where the LAWS come into play. After the Institution completes their inquiry process, they communicate the Research Misconduct Investigation Report to ORI, then ORI determines the actions that they could take with another complex process (§ 93.403 ORI review of research misconduct proceedings and § 93.404 Findings of research misconduct and proposed administrative actions). They can: 1. Close the Case without a finding of research misconduct or Make a finding of research misconduct and proposed administrative actions 2. The findings are summarized in a charge letter to the researcher. A charge means the written notice, as well as any amendments to the notice, that are sent to the respondent stating the findings of research misconduct and any HHS administrative actions. 3. If the respondent disputes the charge letter, they can request a hearing (ecfr.gov/current/title-42/ch…). This is a formal court proceeding at ORI. It is very expensive and time consuming. The result is similar to the prior step of formal charges or a decision that there is no research misconduct. 4. HHS may attempt to settle the case with the researcher to accept the charges or not. Settlement agreements are made public. 5. If there is no settlement, then the HHS a) Provides final notification of Research Misconduct Findings to the respondent, the relevant institution, the complainant, and HHS officials b) Identify publications which require correction or retraction and prepare and send a notice to the relevant journal. c) Publish notice of the research misconduct findings. d)Take any Other Actions Authorized by Law. This is where fraud and other criminal charges come in (i.e. formal accusations and charges of fraud) See how @chris_said skips all the way to the end? —----- Next, I plan to write about The Scientific Misconduct Accusation Scheme and how complainants and their conspirators (@qcmfunds @noMidwestHedgie and others) financially benefit from abuse of these investigative processes. The complainants behind most of these accusations are @schrag_matthew @MicrobiomDigest, @Thatsregrettab1, David Bredt, @geoffrey_pitt and @adrian_h. —------ Organizations that help support science, please reach out to me if you want to help stop the abuse of the scientific investigative processes. @BBRFoundation, @SfNtweets, @Society4Science, @aaas, @hhs_ORI, @HHSGOV Other Useful Links if you want to learn more: grants.nih.gov/policy/resear…
2
25
1
67
5,953
NOT Adam Feuerstein (Parody) retweeted
Latest on #Alzheimers: ift.tt/rF1yKVn No Decline in Cognition Scores in Patients with Mild Alzheimer's Disease Who Received Simufilam Continuo... #Alzheimeric
16
1
40
1,611
NOT Adam Feuerstein (Parody) retweeted
Hello @secgov. This month the Failures to Deliver data that would normally have been published at sec.gov/data/foiadocsfailsda… at the end of October is notable by its absence. For the sake of market transparency, can you please publish the missing data ASAP.
178
533
121
1,356
166,743
NOT Adam Feuerstein (Parody) retweeted
$SAVA Completes Enrollment for Pivotal Phase 3 Program of Simufilam in Alzheimer’s Disease. Top-line results for on-going, 52-week Phase 3 trial are expected by EOY'24. Top-line results for on-going, 76-week Phase 3 trial are expected mid-year 2025.
4
11
2
47
22,749
NOT Adam Feuerstein (Parody) retweeted
Why short when you can #FTD? Probably cheaper and less paperwork. Bonus: if the company goes bankrupt from the damage done to their capital access, broker never has to buy the shares -- ever -- and keeps the money #Household Investors paid for the shares.
52
257
29
949
44,662
NOT Adam Feuerstein (Parody) retweeted
Replying to @MicrobiomDigest
@MicrobiomDigest Bizzy Lizzy has a crush on @MattNachtrab but he is all business. She is very careful with her statements(would be a good lawyer) but her patreon.com/elisabethbik should be published! Who was paying? I guess they are switching to cash.
3
12
33
843
NOT Adam Feuerstein (Parody) retweeted
Matt's coverage of Cassava $SAVA is absolutely incredible. If you're an investor in the stock -- or even if you're just interested in the company -- he is a must-follow here on Twitter.
CUNY Paused / What's Next for $SAVA So the @CityCollegeNY investigation is paused and therefore the @HHS_ORI is likely paused as well. I think ORI has a probe started into CUNY. I have not read the laws on how ORI deals with institutions that receive HHS funds but fail to adhere to research misconduct inquiry laws. I will take a look when I get a chance... But what are the next catalysts for $sava: 1. Jan 2024 - FULL OLE Topline data - Suzanne Hendrix said they will be reporting the 24-month data for the open label study. First I heard it said they plan to release that data. Dosing is complete, so 2 months puts it to Jan for top line results. 2. Nov 2023 - Enrollment complete announcement. 3. Few weeks or Unknown - SEC decision. Likely a positive catalyst. The SEC is likely focused on the "Outside Academic Lab, which was blinded to avoid bias" disclosure. To me, the disclosures over time shifted from "Outside Lab" to "Outside Academic Lab, Blinded to avoid Bias" Everyone knew that meant it was CUNY. To me, that disclosure is sufficient, and the SEC will send a No Action letter to Cassava. Year end was 9/30, so that could come the next few weeks. They could give them a slap on the wrist settlement or sue Cassava if a settlement or No Action is not decided. I don't see the SEC suing Cassava. If it's a small settlement fine or No Action, stock will rocket higher. This could be what is driving short pressure lately... they are overconfident this will be a bad catalyst. They are blind with bias and wrong though. I am at 60% no action, 38% small settlement, 2% lawsuit. 4. Unknown - DOJ decision - There is a much higher threshold of evidence at the DOJ. Similar to the ORI Research Misconduct rules of preponderance of evidence. There is very very low risk of any adverse results of this investigation. I am not familiar with how they end investigations. It is not as clean as the SEC with their No Action letter. 5. Unknown - Fast track or Break Through Therapy Designation. These take 60 day for FDA to make a decision, but we have no idea if and when $sava would decide to apply. It could be soon or it could be after Rethink is done. I hope they do it earlier because there are some benefits (@Vinnie66007649 ?) that could get help things move faster before Rethink readout so they could do an NDA quicker after Rethink. 6. Next couple months - Defamation Suit - Decision around defamation lawsuit dismissal or not. I'd say 50/50 on that at this point. 7. Shareholder lawsuit - I think there is a mediation planned but I don't follow too close. I think its noise. It is VERY expensive for these trolls to go to trial. I think settles for small amount or is dropped. I am not the best source of opinion on this. 8. Q1 2025 - Rethink Data Readout - The event that changes Alzheimer's therapies forever and the world sees the first true hope for controlling this terrible disease. I think this is a 95% probability of success... Market thinks 2%. That is why there is still gigantic upside on this stock. It will be sooo much forking fun to watch.
11
20
7
131
22,807
NOT Adam Feuerstein (Parody) retweeted
$SAVA From a technical standpoint, i repeat, TECHNICAL view , this is the perfect nightmare for shorts. Primary downtrend channel broken on volume, flagging now under the $22 major resistance line. Could squeeze over $22 (+35% of float is sold short w/ a short ratio of 13.1, which mean, shorts will not have time to cover quickly). My focus is always the chart.
4
8
3
58
17,558
NOT Adam Feuerstein (Parody) retweeted
$SAVA as i mentioned b4, the break of $22 could be a serious problem for shorts.
1
3
13
4,308
NOT Adam Feuerstein (Parody) retweeted
$SAVA the short ratio of 13 in a stock with a short interest of 35% is a big problem for shorts. They cant cover quickly without an explosive move on the stock. JMHO
2
7
1
20
5,227
NOT Adam Feuerstein (Parody) retweeted
Elisabeth Bik, @MicrobiomDigest, quickly hid this tweet from her feed. @Jebs_Twit points out the hypocrisy of her comments.
The idea that an investor would refuse to sit on his/her laurels and just take the word of shills working for short sellers is beyond shocking. I mean with all the good reporting and analysis from you yokels. You think posting a photo of a lab book is a breech of the investigation..? thats as intellectually dishonest as the "journalism" coming out of stat news. Due diligence is part of investing. Im surprised a stock gal like you wouldn't know that.
1
8
2
40
3,765
NOT Adam Feuerstein (Parody) retweeted
For four reasons, I decided to release some of the truth and evidence about Dr. Wang and the investigation that the press refuses to report: 1. The investigation is paused and we are likely go many years with no new information regarding the CUNY investigation of the Dr. Wang inquiry. 2. The press has not published any of the available facts demonstrating the investigation was deeply flawed as communicated by me and the $sava legal team. The only coverage of the investigation halt was Apoorva at the NYT. They have had three weeks to do the work and report the truth to correct the record. No articles about CUNY pausing have made the $sava news feed, but a leaked report does and drops the stock 50% afterhours. 3. The press has not covered the obvious, publicly available, inappropriate communication between the lead investigator and Adrian Heilbut and Elisabeth Bik on Twitter. 4. The press is deeply biased against Dr. Wang and was spoon fed the original allegations from the short sellers as evidenced in the New Yorker article. I have given them the information in this tweet and they have chosen not to report on it. The outcome of the investigation into Dr. Wang at CUNY was decided by the investigative team before a good faith attempt was made to learn the facts. Orie Shafer, lead investigator of Dr. Wang, showed his bias in his tweet on Feb 5th 2022 to Elisabeth Bik and Adrian Heilbut (known short sellers and detractors of Dr. Wang) when he said “Am planning an ethics discussion on the recent AD drug fiascos in the news. Would love to discuss if you have the time.” He said this while he was the lead investigator of Dr. Wang at CUNY. Why hasn’t the press reported on this? It is clear evidence in the public record. He showed admiration of Elisabeth Bik in another tweet the same day when he said "No decent research ethics course involving the life sciences would omit the excellent and important work of @MicrobiomDigest " Orie Shafter’s last record of his twitter account before he deleted it was May 12th 2023 after tweeting many times nearly every day for years. Charles Piller reported that the final report was completed 5 months prior to his article or May 12th 2023. Why did he delete his twitter? The investigation as described in policy did a search of Dr. Wangs lab to retain IT systems, lab equipment with data on them (i.e. densometer), notebooks, and other physical items. The Investigative committee noted a repeated pattern of blaming CCNY IT for the lack of data management in his lab. By all accounts the computers provided by CCNY IT were very old and lacked proper maintenance and data backup. Dr. Wang’s lab had one hard drive die years ago. CCNY IT destroyed the hard drive in his densitometer during their evidence gathering. It is the responsibility of the university to provide IT infrastructure to researchers. Dr. Wang has strong evidence that IT mismanagement contributed to significant data loss. The investigation committee lightly referenced Dr. Wang blamed IT for issues but did they talk to IT about the systems in his lab? Did they examine the destroyed hard drives in question? Did they review records of IT equipment provided to Dr. Wang over the decades and how often it was replaced? Did they examine communication regarding IT infrastructure or requests from the university to clean out labs or to assist in issues? It does not appear they did any of this work. The last page of the investigation report said “Already frustrated by the respondent’s inability to provide even a single datum or notebook in response to any allegation…”, which is simply not true. He delivered 1000s of images and Dr. Wang has notebooks that he recorded information of his experiments in and blinded data results related to the allegations. The investigative team searched his lab where many notebooks were present. Did they have the notebooks and lie on the report? Did they miss them in the search and failed to effectively communicate with Dr. Wang to help inventory evidence they found? I have seen some of these notebooks and pages, and I see no harm in sharing the attached image as evidence that there are notebooks that exist that were in the lab the whole time. Given that the investigation had severe flaws, literally destroyed data, misrepresented the data and notebooks they claim do not exist, it's leaked report made no finding that Dr. Wang committed research misconduct, the next investigation will almost certainly result in the university clearing Dr Wang of research misconduct. I will put article links, tweet images, and links mentioned here in replies to this tweet.
59
63
20
236
160,407
NOT Adam Feuerstein (Parody) retweeted
Replying to @adamfeuerstein
@adamfeuerstein tries hard to tell @US_FDA to halt SAVA trials irrespective Simufilam is safe as confirmed by DSMB. He lied & misinterpreted information. Damages were done to benefit his colluders against AD patients & investors. I hope @SECGov @DOJCrimDiv will investigate.
1
21
3
75
6,303
NOT Adam Feuerstein (Parody) retweeted
Another positive new development: "The MRI data suggest simufilam is not associated with treatment-emergent amyloid-related imaging abnormalities, or ARIA." Looking like $SAVA's simufilam has a more attractive safety profile than $BIIB's approved drugs. cassavasciences.com/news-rel…
There is a race underway to treat Alzheimer’s Disease. Here is a recap comparison of Cassava $SAVA's simufilam to the two other FDA-approved drugs available from Biogen $BIIB (Aduhelm and Leqembi). And also Eli Lilly's $LLY drug that's in P3 trials (donanemab). 🧵
6
14
2
76
11,767
NOT Adam Feuerstein (Parody) retweeted
Funny that @adamfeuerstein says NO ONE at #CTAD23 is talking about $sava... But he's talking about $sava at #CTAD23. Hmmm.... Maybe he thought his horribly written arrogant piece demanding the FDA halt a safe AD trial of simufilam would get more comments from his two fans. If he was worth the ink he wastes, he would have read the sham of an investigation report that he ranted about for 1000 words. @statnews needs to fire this fool.
11
17
4
82
5,986
NOT Adam Feuerstein (Parody) retweeted
Did you know if you hold an ermine up to your ear, you can hear what it’s like to be attacked by an ermine?
1,239
21,164
2,152
147,734
8,854,500
NOT Adam Feuerstein (Parody) retweeted
You know wha ChatGPT can’t do? Your pushups for you. Get your ass to the gym.
166
502
59
4,559
432,260
NOT Adam Feuerstein (Parody) retweeted
[first day as a superhero] Villain: Why is my calendar wrapped in aluminum? Me: I foiled your plans. [I am immediately killed]
9
165
5
1,784
151,658